Alan F. Denenberg
Lawyers

Filters
Seer $336 million IPO and concurrent private placement
Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 10,592,106 shares of Class A common stock of Seer, Inc. at $19.00 per…
BeiGene $340 million secondary offering
Davis Polk advised the underwriter in connection with the $340 million SEC-registered offering of 1,511,546 American depositary shares of BeiGene, Ltd. by certain existing ADS holders. The…
Maravai LifeSciences Holdings $1.863 billion IPO
Davis Polk advised the representatives of the several underwriters in connection with the initial public offering of 69,000,000 shares of Class A common stock of Maravai LifeSciences…
Berkeley Lights $258 million secondary offering
Davis Polk advised the representatives of the several underwriters in connection with the $258 million SEC-registered offering of 3,000,000 shares of common stock of Berkeley Lights,…
Microchip Technology $1.1 billion convertible notes exchanges
Davis Polk is advising the financial adviser to Microchip Technology Incorporated in connection with Microchip’s privately negotiated exchanges of $90 million aggregate principal amount of…
Olema Pharmaceuticals $240 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $240 million initial public offering of 12,650,000 shares of common stock of Olema Oncology at $19…
Kodiak Sciences $645 million follow-on offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $645.0 million public offering of 5,972,222 shares of common stock by…
Allakos $272 million follow-on offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the follow-on offering of 3,506,098 shares of common stock of Allakos Inc…
Turning Point Therapeutics $460 million stock offering
Davis Polk advised the joint book-running managers in connection with a $460 million SEC-registered common stock offering by Turning Point Therapeutics, Inc. The common stock is listed…
Aligos Therapeutics $150 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $150 million initial public offering of 10,000,000 shares of common stock of Aligos…